Amicus Therapeutics Inc (FOLD)
10.71
-0.11
(-1.02%)
USD |
NASDAQ |
Apr 23, 16:00
10.70
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Profit Margin (Quarterly): -29.41% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -29.41% |
| September 30, 2023 | -20.85% |
| June 30, 2023 | -45.75% |
| March 31, 2023 | -61.36% |
| December 31, 2022 | -63.41% |
| September 30, 2022 | -40.75% |
| June 30, 2022 | -76.99% |
| March 31, 2022 | -108.3% |
| December 31, 2021 | -101.4% |
| September 30, 2021 | -63.23% |
| June 30, 2021 | -66.17% |
| March 31, 2021 | -98.89% |
| December 31, 2020 | -101.2% |
| September 30, 2020 | -94.92% |
| June 30, 2020 | -84.19% |
| March 31, 2020 | -147.0% |
| December 31, 2019 | -162.3% |
| September 30, 2019 | -126.7% |
| June 30, 2019 | -191.6% |
| March 31, 2019 | -353.3% |
| December 31, 2018 | -239.2% |
| September 30, 2018 | -772.8% |
| June 30, 2018 | -290.2% |
| March 31, 2018 | -299.0% |
| December 31, 2017 | -469.9% |
| Date | Value |
|---|---|
| September 30, 2017 | -1.03K% |
| June 30, 2017 | -672.5% |
| March 31, 2017 | -1.32K% |
| December 31, 2016 | -2.07K% |
| September 30, 2016 | -2.19K% |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | -5.85K% |
| June 30, 2014 | -3.08K% |
| March 31, 2014 | -3.50K% |
| December 31, 2013 | -3.78K% |
| September 30, 2013 | -37.41K% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | -87.83% |
| March 31, 2012 | -169.0% |
| December 31, 2011 | -153.9% |
| September 30, 2011 | -168.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-191.6%
Minimum
Jun 2019
-20.85%
Maximum
Sep 2023
-88.65%
Average
-84.19%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| TG Therapeutics Inc | -32.79% |
| Geron Corp | -226.0K% |
| Vanda Pharmaceuticals Inc | -5.30% |
| Fate Therapeutics Inc | -2.63K% |
| Editas Medicine Inc | -31.43% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -120.2% |
| Return on Assets | -20.50% |
| Return on Invested Capital | -29.26% |
| Gross Profit Margin (Quarterly) | 90.16% |
| Operating Margin (Quarterly) | -3.21% |
| Return on Net Operating Assets | -38.40% |